Personnel Demonstration Project at the Defense Health Agency, Research and Development Science and Technology Reinvention Laboratory (STRL), 89621-89622 [2024-26267]

Download as PDF lotter on DSK11XQN23PROD with NOTICES1 Federal Register / Vol. 89, No. 219 / Wednesday, November 13, 2024 / Notices respondents, including the use of automated collection techniques or other forms of information technology. The Office of Management and Budget (OMB) has approved this information collection for use under Control Number 0704–0231 through March 31, 2025. DoD proposes that OMB approve an extension of the information collection requirement, to expire three years after the approval date. DATES: DoD will consider all comments received by January 13, 2025. ADDRESSES: You may submit comments, identified by OMB Control Number 0704–0231, using either of the following methods: o Federal eRulemaking Portal: https:// www.regulations.gov. Follow the instructions for submitting comments. o Email: osd.dfars@mail.mil. Include OMB Control Number 0704–0231 in the subject line of the message. Comments received generally will be posted without change to https:// www.regulations.gov, including any personal information provided. FOR FURTHER INFORMATION CONTACT: Ms. Saleemah McMillan, at 202–308–5383. SUPPLEMENTARY INFORMATION: Title and OMB Number: Defense Federal Acquisition Regulation Supplement (DFARS) Part 237, Service Contracting, associated DFARS Clauses at DFARS 252.237, DD Form 2062, and DD Form 2063; OMB Control Number 0704–0231. Affected Public: Businesses or other for-profit and not-for-profit institutions. Respondent’s Obligation: Required to obtain or retain benefits. Frequency: On occasion. Number of Respondents: 7,018. Responses Per Respondent: 3.8. Annual Responses: 26,564. Average Burden Per Response: 1.01 hours. Annual Burden Hours: 26,738. Needs and Uses: This information collection is used for the following purposes— a. The information collected pursuant to paragraph (c) of the solicitation provision at DFARS 252.237–7000, Notice of Special Standards of Responsibility, is used to verify that the offeror is properly licensed in the state or other political jurisdiction in which the offeror operates its professional practice. b. The contract clause at DFARS 252.237–7011, Preparation History; the DD Form 2062, Record of Preparation and Disposition of Remains (Outside CONUS); and the DD Form 2063, Record of Preparation and Disposition of Remains (Within CONUS) are used to verify that the deceased’s remains have been properly cared for by the mortuary contractor. VerDate Sep<11>2014 17:40 Nov 12, 2024 Jkt 265001 c. The written plan required by the solicitation provision at DFARS 252.237–7024, Notice of Continuation of Essential Contractor Services, submitted by offerors concurrently with the proposal or offer, allows the contracting officer to assess the offeror’s capability to continue providing contractually required services to support the DoD component’s mission-essential functions during periods of crisis. d. The information collected pursuant to the contract clause at DFARS 252.237–7023, Continuation of Essential Contractor Services, allows the contracting officer to provide approval of updates to the contractor’s plan provided under the provision at DFARS 252.237–7024, to ensure that the contractor can continue to provide services in support of the DoD component’s required mission-essential functions during crisis situations. Jennifer D. Johnson, Editor/Publisher, Defense Acquisition Regulations System. [FR Doc. 2024–26234 Filed 11–12–24; 8:45 am] BILLING CODE 6001–FR–P DEPARTMENT OF DEFENSE Office of the Secretary [Docket ID: DoD–2024–OS–0118] Personnel Demonstration Project at the Defense Health Agency, Research and Development Science and Technology Reinvention Laboratory (STRL) Under Secretary of Defense for Research and Engineering (USD(R&E)), Department of Defense (DoD). ACTION: Notice. AGENCY: This serves as notice of the proposed adoption of an STRL personnel demonstration project plan and additional flexibilities by the Defense Health Agency, Research and Development (DHA R&D), a DoD STRL. DHA R&D is an STRL comprised of medical research organizations that were formerly components of Military Department organizations, including the U.S. Army Medical Research and Development Command (USAMRDC), a successor to the U.S. Army Medical Research and Material Command (USAMRMC). The DHA R&D proposes to adopt the personnel demonstration project plan of the USAMRDC at the Federal Register issue of March 3, 1998. In addition, DHA R&D proposes to adopt certain personnel flexibilities available to all DoD STRLs. SUMMARY: PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 89621 This proposal may not be implemented until a 30-day comment period is provided, comments addressed, and a final Federal Register notice published. To be considered, written comments must be submitted on or before December 13, 2024. ADDRESSES: You may submit comments, identified by docket number and title, by any of the following methods: Federal eRulemaking Portal: https:// www.regulations.gov. Follow the instructions for submitting comments. Mail: Department of Defense, Office of the Assistant to the Secretary of Defense for Privacy, Civil Liberties, and Transparency, Regulatory Directorate, 4800 Mark Center Drive, Attn: Mailbox 24, Suite 05F16, Alexandria, VA 22350– 1700. Instructions: All submissions must include the agency name, docket number and title for this Federal Register document. The general policy for comments and other submissions from members of the public is to make these submissions available for public viewing on the internet at https:// www.regulations.gov as they are received without change, including any personal identifiers or contact information. FOR FURTHER INFORMATION CONTACT: • DHA R&D STRL: Linda Krout, 301– 619–7276, linda.j.krout.civ@health.mil. • Office of Under Secretary of Defense (Research and Engineering), DoD Laboratories, Defense Research Enterprise: Julia Parakkat, 703–625– 5768, julia.b.parakkat.civ@mail.mil. SUPPLEMENTARY INFORMATION: Pursuant to section 4121 of title 10, United States Code (U.S.C.), the Secretary of Defense is authorized to conduct personnel demonstration projects at laboratories designated as DoD STRLs. DoD STRLs must have an approved personnel demonstration project plan published in an FRN and fulfill any collective bargaining obligations before implementing the demonstration project or adopting the flexibilities available to other DoD STRL demonstration projects. In implementing this plan, DHA R&D will establish internal operating procedures as appropriate. DATES: 1. Background A personnel demonstration project was implemented at the USAMRMC in accordance with the plan at 63 FR 10440 (March 3, 1998). In 2019, the USAMRMC was redesignated as the USAMRDC and the personnel demonstration project notice at 63 FR 10440 was updated through a minor modification on August 30, 2019, to reflect this change. On May 5, 2024, E:\FR\FM\13NON1.SGM 13NON1 89622 Federal Register / Vol. 89, No. 219 / Wednesday, November 13, 2024 / Notices lotter on DSK11XQN23PROD with NOTICES1 following the transfer of USAMRDC components to DHA R&D, the Deputy Assistant Secretary of Defense for Science and Technology Foundations designated DHA R&D as a DoD STRL. DHA R&D has implemented the USAMRDC personnel demonstration project authorities for the DHA R&D components that were formerly subordinate components of USAMRDC. This notice proposes to implement the personnel demonstration project for all DHA R&D components by adopting the USAMRDC personnel demonstration project plan and other flexibilities available to all DoD STRLs. The purpose of the demonstration project is to demonstrate that the effectiveness of DoD organizations can be enhanced by allowing greater managerial control over personnel functions and, at the same time, expand the opportunities available to employees through a more responsive and flexible personnel system. 2. DHA R&D Personnel Demonstration Project Plan The demonstration project will cover approximately 1,224 DHA R&D positions. Approximately 59 percent of covered positions are at the following DHA R&D organizations located at Fort Detrick, Maryland: Medical Research and Development, Telemedicine and Advanced Technology Research, Medical Research Institute of Infectious Disease, Medical Research Acquisition Activity, and Medical Materiel Development Activity. The remaining positions are at the following sites: Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland; Walter Reed Institute of Research, Forest Glen, Silver Spring, Maryland; Institute of Surgical Research and the Burn Center Directorate, Joint Base San Antonio, Texas. The majority of these positions transferred to DHA R&D from USAMRDC. DHA R&D has successfully implemented the USAMRDC personnel demonstration project authorities for DHA R&D components that were formerly subordinate organizations of USAMRDC. Based on experience gained and following careful consideration, DHA R&D has determined to conduct a personnel demonstration project for all DHA R&D components by adopting the USAMRDC personnel demonstration project plan and other flexibilities available to all DoD STRLs. The DHA R&D will adopt the USAMRDC Personnel Demonstration Project plan outlined in 63 FR 10440 (March 3, 1998), including the following modifications approved pursuant to DoD Instruction 3201.05: minor VerDate Sep<11>2014 17:40 Nov 12, 2024 Jkt 265001 modification to administrative occupational family, DJ 03 and 04 band structure of occupational series 1102 only (February 3, 2011); minor modification to pay for performance payment timeframe (January 5, 2018); minor modification to participating occupational series (November 28, 2022). Upon implementation of this personnel demonstration project, DHA R&D will also adopt the following flexibilities that are available to all DoD STRLs: • 89 FR 44648 (May 21, 2024) • 88 FR 10874 (February 22, 2023) • 87 FR 72462 (November 25, 2022) • 87 FR 58334 (September 26, 2022) • 87 FR 40200 (July 6, 2022) • 85 FR 78829 (December 7, 2020) • 85 FR 5639 (January 31, 2020) • 82 FR 43339 (September 15, 2017) • 82 FR 29280 (June 28, 2017) • 79 FR 43722 (July 28, 2014) • 78 FR 29335 (May 20, 2013) Dated: November 7, 2024. Aaron T. Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2024–26267 Filed 11–12–24; 8:45 am] BILLING CODE 6001–FR–P DEPARTMENT OF ENERGY Bonneville Power Administration [BPA File No.: TC–26] Proposed Modifications to Open Access Transmission Tariff; Public Hearing and Opportunities for Public Review and Comment Bonneville Power Administration (Bonneville), Department of Energy (DOE). ACTION: Notice of public hearing and opportunity to review and comment. AGENCY: Bonneville is initiating a proceeding pursuant to Bonneville’s open access transmission tariff (Tariff) and the Federal Power Act to modify the non-rate terms and conditions for transmission, ancillary, and interconnection services in the Tariff. The proposed modifications will be effective on October 1, 2025. Bonneville has designated this proceeding Docket No. TC–26. DATES: Prehearing Conference: The prehearing conference in the TC–26 proceeding will be held on November 15, 2024, at 2:00 p.m. The ADDRESSES section of this notice provides details on participating in the prehearing conference. Intervention: Petitions to intervene in the TC–26 proceeding must be filed on SUMMARY: PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 Bonneville’s secure website no later than 4:30 p.m. on December 3, 2024. Part III of this notice, ‘‘Public Participation in TC–26,’’ provides details on requesting access to the secure website and filing a petition to intervene. Participant Comments: Written comments by non-party participants must be received by December 5, 2024, to be considered in the Hearing Officer’s recommended decision and the Administrator’s Record of Decision (ROD). See Part III of this notice for more information about submitting participant comments. ADDRESSES: Prehearing Conference: The prehearing conference in the TC–26 proceeding will be held in the Bonneville Rates Hearing Room, 1201 NE Lloyd Boulevard, Suite 200, Portland, Oregon 97232. Interested parties may attend in person or participate virtually via WebEx. The WebEx information will be available on Bonneville’s TC–26 tariff proceeding web page at https://www.bpa.gov/tc26 or from the Hearing Clerk at TC26clerk@ gmail.com. Intervention: Anyone intending to become a party to the TC–26 tariff proceeding must file a petition to intervene on Bonneville’s secure website. Petitions to intervene may be filed beginning on the date of publication of this notice and are due no later than 4:30 p.m. on December 3, 2024. Part III of this notice, ‘‘Public Participation in TC–26,’’ provides details on requesting access to the secure website and filing a petition to intervene. Participant Comments: Written comments by non-party participants may be submitted through Bonneville’s website at www.bpa.gov/comment or by hard copy to: BPA Public Involvement, Bonneville Power Administration, P.O. Box 14428, Portland, Oregon 97293. Part III of this notice, ‘‘Public Participation in TC–26,’’ provides details on submitting participant comments. FOR FURTHER INFORMATION CONTACT: Elissa Haley, DKS–7, BPA Communications, Bonneville Power Administration, P.O. Box 14428, Portland, Oregon 97293; by phone tollfree at 1–800–622–4519; or by email to enhaley@bpa.gov. The Hearing Clerk for this proceeding can be reached via email at TC26clerk@ gmail.com or via telephone at (503) 479–8506. Please direct questions regarding Bonneville’s secure website to the Hearing Coordinator via email at cwgriffen@bpa.gov or, if the question is E:\FR\FM\13NON1.SGM 13NON1

Agencies

[Federal Register Volume 89, Number 219 (Wednesday, November 13, 2024)]
[Notices]
[Pages 89621-89622]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-26267]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary

[Docket ID: DoD-2024-OS-0118]


Personnel Demonstration Project at the Defense Health Agency, 
Research and Development Science and Technology Reinvention Laboratory 
(STRL)

AGENCY: Under Secretary of Defense for Research and Engineering 
(USD(R&E)), Department of Defense (DoD).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This serves as notice of the proposed adoption of an STRL 
personnel demonstration project plan and additional flexibilities by 
the Defense Health Agency, Research and Development (DHA R&D), a DoD 
STRL. DHA R&D is an STRL comprised of medical research organizations 
that were formerly components of Military Department organizations, 
including the U.S. Army Medical Research and Development Command 
(USAMRDC), a successor to the U.S. Army Medical Research and Material 
Command (USAMRMC). The DHA R&D proposes to adopt the personnel 
demonstration project plan of the USAMRDC at the Federal Register issue 
of March 3, 1998. In addition, DHA R&D proposes to adopt certain 
personnel flexibilities available to all DoD STRLs.

DATES: This proposal may not be implemented until a 30-day comment 
period is provided, comments addressed, and a final Federal Register 
notice published. To be considered, written comments must be submitted 
on or before December 13, 2024.

ADDRESSES: You may submit comments, identified by docket number and 
title, by any of the following methods:
    Federal eRulemaking Portal: https://www.regulations.gov. Follow the 
instructions for submitting comments.
    Mail: Department of Defense, Office of the Assistant to the 
Secretary of Defense for Privacy, Civil Liberties, and Transparency, 
Regulatory Directorate, 4800 Mark Center Drive, Attn: Mailbox 24, Suite 
05F16, Alexandria, VA 22350-1700.
    Instructions: All submissions must include the agency name, docket 
number and title for this Federal Register document. The general policy 
for comments and other submissions from members of the public is to 
make these submissions available for public viewing on the internet at 
https://www.regulations.gov as they are received without change, 
including any personal identifiers or contact information.

FOR FURTHER INFORMATION CONTACT: 
     DHA R&D STRL: Linda Krout, 301-619-7276, 
[email protected].
     Office of Under Secretary of Defense (Research and 
Engineering), DoD Laboratories, Defense Research Enterprise: Julia 
Parakkat, 703-625-5768, [email protected].

SUPPLEMENTARY INFORMATION: Pursuant to section 4121 of title 10, United 
States Code (U.S.C.), the Secretary of Defense is authorized to conduct 
personnel demonstration projects at laboratories designated as DoD 
STRLs. DoD STRLs must have an approved personnel demonstration project 
plan published in an FRN and fulfill any collective bargaining 
obligations before implementing the demonstration project or adopting 
the flexibilities available to other DoD STRL demonstration projects. 
In implementing this plan, DHA R&D will establish internal operating 
procedures as appropriate.

1. Background

    A personnel demonstration project was implemented at the USAMRMC in 
accordance with the plan at 63 FR 10440 (March 3, 1998). In 2019, the 
USAMRMC was redesignated as the USAMRDC and the personnel demonstration 
project notice at 63 FR 10440 was updated through a minor modification 
on August 30, 2019, to reflect this change. On May 5, 2024,

[[Page 89622]]

following the transfer of USAMRDC components to DHA R&D, the Deputy 
Assistant Secretary of Defense for Science and Technology Foundations 
designated DHA R&D as a DoD STRL. DHA R&D has implemented the USAMRDC 
personnel demonstration project authorities for the DHA R&D components 
that were formerly subordinate components of USAMRDC. This notice 
proposes to implement the personnel demonstration project for all DHA 
R&D components by adopting the USAMRDC personnel demonstration project 
plan and other flexibilities available to all DoD STRLs.
    The purpose of the demonstration project is to demonstrate that the 
effectiveness of DoD organizations can be enhanced by allowing greater 
managerial control over personnel functions and, at the same time, 
expand the opportunities available to employees through a more 
responsive and flexible personnel system.

2. DHA R&D Personnel Demonstration Project Plan

    The demonstration project will cover approximately 1,224 DHA R&D 
positions. Approximately 59 percent of covered positions are at the 
following DHA R&D organizations located at Fort Detrick, Maryland: 
Medical Research and Development, Telemedicine and Advanced Technology 
Research, Medical Research Institute of Infectious Disease, Medical 
Research Acquisition Activity, and Medical Materiel Development 
Activity. The remaining positions are at the following sites: Medical 
Research Institute of Chemical Defense, Aberdeen Proving Ground, 
Maryland; Walter Reed Institute of Research, Forest Glen, Silver 
Spring, Maryland; Institute of Surgical Research and the Burn Center 
Directorate, Joint Base San Antonio, Texas. The majority of these 
positions transferred to DHA R&D from USAMRDC. DHA R&D has successfully 
implemented the USAMRDC personnel demonstration project authorities for 
DHA R&D components that were formerly subordinate organizations of 
USAMRDC. Based on experience gained and following careful 
consideration, DHA R&D has determined to conduct a personnel 
demonstration project for all DHA R&D components by adopting the 
USAMRDC personnel demonstration project plan and other flexibilities 
available to all DoD STRLs.
    The DHA R&D will adopt the USAMRDC Personnel Demonstration Project 
plan outlined in 63 FR 10440 (March 3, 1998), including the following 
modifications approved pursuant to DoD Instruction 3201.05: minor 
modification to administrative occupational family, DJ 03 and 04 band 
structure of occupational series 1102 only (February 3, 2011); minor 
modification to pay for performance payment timeframe (January 5, 
2018); minor modification to participating occupational series 
(November 28, 2022). Upon implementation of this personnel 
demonstration project, DHA R&D will also adopt the following 
flexibilities that are available to all DoD STRLs:

 89 FR 44648 (May 21, 2024)
 88 FR 10874 (February 22, 2023)
 87 FR 72462 (November 25, 2022)
 87 FR 58334 (September 26, 2022)
 87 FR 40200 (July 6, 2022)
 85 FR 78829 (December 7, 2020)
 85 FR 5639 (January 31, 2020)
 82 FR 43339 (September 15, 2017)
 82 FR 29280 (June 28, 2017)
 79 FR 43722 (July 28, 2014)
 78 FR 29335 (May 20, 2013)

    Dated: November 7, 2024.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2024-26267 Filed 11-12-24; 8:45 am]
BILLING CODE 6001-FR-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.